Glioblastomas with IDH1/2 mutations have a short clinical history and have a favorable clinical outcome.
about
Association of The IDH1 C.395G>A (R132H) Mutation with Histological Type in Malay Brain TumorsRedox-Related Epigenetic Mechanisms in Glioblastoma: Nuclear Factor (Erythroid-Derived 2)-Like 2, Cobalamin, and Dopamine Receptor Subtype 4PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database.The Clinical Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis.
P2860
Glioblastomas with IDH1/2 mutations have a short clinical history and have a favorable clinical outcome.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Glioblastomas with IDH1/2 muta ...... a favorable clinical outcome.
@en
Glioblastomas with IDH1/2 muta ...... a favorable clinical outcome.
@nl
type
label
Glioblastomas with IDH1/2 muta ...... a favorable clinical outcome.
@en
Glioblastomas with IDH1/2 muta ...... a favorable clinical outcome.
@nl
prefLabel
Glioblastomas with IDH1/2 muta ...... a favorable clinical outcome.
@en
Glioblastomas with IDH1/2 muta ...... a favorable clinical outcome.
@nl
P2093
P2860
P356
P1476
Glioblastomas with IDH1/2 muta ...... a favorable clinical outcome.
@en
P2093
Akihiko Yoshida
Hideyuki Arita
Hirokazu Takami
Koichi Ichimura
Makoto Ohno
Motoki Yonezawa
Shintaro Fukushima
Soichiro Shibui
Yasuji Miyakita
Yoshitaka Narita
P2860
P356
10.1093/JJCO/HYV170
P577
2015-11-24T00:00:00Z